TheEdgeResearch
Home / Stocks / JEMA

JPMorgan ActiveBuilders Emerging Markets Equity ETF (JEMA)

NASDAQ Financial Services Asset Management
$61.60 ▲ +1.63%
Market Cap
$1.79B
Sector
Financial Services
Industry
Asset Management
Beta
1.04
52-Wk Range
44.22-66.68
CEO
Country
US
Currency
USD

JPMorgan ActiveBuilders Emerging Markets Equity ETF operates in the Asset Management industry of the Financial Services sector, headquartered in New York, NY, US. The stock last traded at $61.60, up 1.63% on the session, giving a market capitalisation of $1.79B. Its beta of 1.04 implies it has historically moved more than the broad market.

Company profile
Exchange
NASDAQ
Employees
IPO date
2021-03-10
Headquarters
New York, NY, US
About JPMorgan ActiveBuilders Emerging Markets Equity ETF

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan ActiveBuilders Emerging Markets Equity ETF is an exchange traded fund launched and managed by J.P. Morgan Investment Management Inc. The fund invests in public equity markets of global emerging region. It invests in stocks of companies operating across diversified sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund invests in stocks of companies that are deemed socially conscious in their business dealings and directly promote environmental responsibility. It employs fundamental and quantitative analysis with bottom-up and top-down stock picking approach to create its portfolio. It seeks to benchmark the performance of its portfolio against the MSCI Emerging Markets Index (Net Total Return). J.P. Morgan Exchange-Traded Fund Trust - JPMorgan ActiveBuilders Emerging Markets Equity ETF was formed on March 10, 2021 and is domiciled in the United States.

Comparable companies

JPMorgan ActiveBuilders Emerging Markets Equity ETF is most often compared with the following Financial Services names:

DHSEMGFICOWINFLRODMRPVRSSLSCHYSPGMXCEM
More research on JEMA
JEMA technical analysis JEMA TheEdge Score Compare against peers
Open full interactive analysis & DCF →